Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AVXL
AVXL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AVXL News
Anavex Advances Blarcamesine into Clinical Studies Targeting CNS Disorders
6d ago
Newsfilter
Biotech Landscape Update: Regulatory Approvals and Mergers
Mar 27 2026
NASDAQ.COM
EMA's CHMP: Withdrawal of Initial Marketing Authorization Application for Blarcamesine Anavex.
Mar 27 2026
moomoo
Anavex Life Sciences Under Investigation for Securities Fraud
Mar 27 2026
PRnewswire
Anavex Withdraws Marketing Application for Alzheimer's Drug Blarcamesine in EU
Mar 25 2026
NASDAQ.COM
Anavex Withdraws Alzheimer’s Drug Application, Shares Plunge Over 20%
Mar 25 2026
stocktwits
Anavex Withdraws Alzheimer’s Drug Application Amid Regulatory Setback
Mar 25 2026
seekingalpha
AVXL Shares Plummet as Anavex Cancels EU Application for Alzheimer's Treatment
Mar 25 2026
stocktwits
Anavex Withdraws Marketing Application for Alzheimer's Drug in EU
Mar 25 2026
Newsfilter
Anavex Reports Significant Alzheimer’s Drug Data Improvements
Mar 23 2026
stocktwits
Anavex Life Sciences Stock Surges 43% Year-to-Date Amid Mixed Outlook
Mar 04 2026
Benzinga
Anavex Life Sciences to Present at Citizens Life Sciences Conference
Mar 03 2026
Newsfilter
Anavex to Present at TD Cowen Health Care Conference
Feb 25 2026
Newsfilter
Anavex Appoints New Board Member
Feb 23 2026
Newsfilter
Anavex Life Sciences Q1 2026 Earnings Call Insights
Feb 09 2026
seekingalpha
Anavex Life Sciences Q1 Earnings Beat Expectations
Feb 09 2026
seekingalpha
Show More News
